Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Stephen J Moore"'
Autor:
Stephanie Ascough, Rebecca J Ingram, Karen K Chu, Catherine J Reynolds, Julie A Musson, Mehmet Doganay, Gökhan Metan, Yusuf Ozkul, Les Baillie, Shiranee Sriskandan, Stephen J Moore, Theresa B Gallagher, Hugh Dyson, E Diane Williamson, John H Robinson, Bernard Maillere, Rosemary J Boyton, Daniel M Altmann
Publikováno v:
PLoS Pathogens, Vol 10, Iss 5, p e1004085 (2014)
Bacillus anthracis produces a binary toxin composed of protective antigen (PA) and one of two subunits, lethal factor (LF) or edema factor (EF). Most studies have concentrated on induction of toxin-specific antibodies as the correlate of protective i
Externí odkaz:
https://doaj.org/article/2a3497e4431447f1bf25d62970f3f8fb
Autor:
Joshua M Kogot, Yanting Zhang, Stephen J Moore, Paul Pagano, Dimitra N Stratis-Cullum, David Chang-Yen, Marek Turewicz, Paul M Pellegrino, Andre de Fusco, H Tom Soh, Nancy E Stagliano
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e26925 (2011)
Bacterial surface peptide display has gained popularity as a method of affinity reagent generation for a wide variety of applications ranging from drug discovery to pathogen detection. In order to isolate the bacterial clones that express peptides wi
Externí odkaz:
https://doaj.org/article/694fa127694b47aaa600ab6704739303
Autor:
Stephanie Ascough, Rebecca J. Ingram, Karen K. Y. Chu, Stephen J. Moore, Theresa Gallagher, Hugh Dyson, Mehmet Doganay, Gökhan Metan, Yusuf Ozkul, Les Baillie, E. Diane Williamson, John H. Robinson, Bernard Maillere, Rosemary J. Boyton, Daniel M. Altmann
Publikováno v:
Vaccines, Vol 10, Iss 10, p 1571 (2022)
The causative agent of anthrax, Bacillus anthracis, evades the host immune response and establishes infection through the production of binary exotoxins composed of Protective Antigen (PA) and one of two subunits, lethal factor (LF) or edema factor (
Externí odkaz:
https://doaj.org/article/f4a45dbbf1d740b49ccfbc1e65929d9a
Autor:
Leila M. Boustany, Sherry L. LaPorte, Laurie Wong, Clayton White, Veena Vinod, Joel Shen, Wendy Yu, David Koditek, Michael B. Winter, Stephen J. Moore, Li Mei, Linnea Diep, Yuanhui Huang, Shouchun Liu, Olga Vasiljeva, Jim West, Jennifer Richardson, Bryan Irving, Marcia Belvin, W. Michael Kavanaugh
Publikováno v:
Cancer Research. 82:4288-4298
T cell–engaging bispecific antibodies (TCB) are highly potent therapeutics that can recruit and activate cytotoxic T cells to stimulate an antitumor immune response. However, the development of TCBs against solid tumors has been limited by signific
Autor:
Shweta Singh, Laura Serwer, Amy DuPage, Kristi Elkins, Niharika Chauhan, Matthew Ravn, Fritz Buchanan, Leyu Wang, Michael Krimm, Ken Wong, Jason Sagert, Kimberly Tipton, Stephen J. Moore, Yuanhui Huang, Andrew Jang, Eric Ureno, Adam Miller, Sarah Patrick, Shanti Duvur, Shouchun Liu, Olga Vasiljeva, Yingchun Li, Tracy Henriques, Ilaria Badagnani, Shawn Jeffries, Siew Schleyer, Rob Leanna, Claus Krebber, Sridhar Viswanathan, Luc Desnoyers, Jonathan Terrett, Marcia Belvin, Susan Morgan-Lappe, W. Michael Kavanaugh, Jennifer Richardson
Publikováno v:
Molecular Cancer Therapeutics. 21:1326-1336
Probody therapeutics (Pb-Txs) are conditionally activated antibody–drug conjugates (ADCs) designed to remain inactive until proteolytically activated in the tumor microenvironment, enabling safer targeting of antigens expressed in both tumor and no
Autor:
Jennifer Richardson, W. Michael Kavanaugh, Susan Morgan-Lappe, Marcia Belvin, Jonathan Terrett, Luc Desnoyers, Sridhar Viswanathan, Claus Krebber, Rob Leanna, Siew Schleyer, Shawn Jeffries, Ilaria Badagnani, Tracy Henriques, Yingchun Li, Olga Vasiljeva, Shouchun Liu, Shanti Duvur, Sarah Patrick, Adam Miller, Eric Ureno, Andrew Jang, Yuanhui Huang, Stephen J. Moore, Kimberly Tipton, Jason Sagert, Ken Wong, Michael Krimm, Leyu Wang, Fritz Buchanan, Matthew Ravn, Niharika Chauhan, Kristi Elkins, Amy DuPage, Laura Serwer, Shweta Singh
Supplementary Data from Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody–Drug Conjugate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::734c4baf0734abf8c7e252b8e10c6fd0
https://doi.org/10.1158/1535-7163.22523304.v1
https://doi.org/10.1158/1535-7163.22523304.v1
Autor:
W. Michael Kavanaugh, Marcia Belvin, Bryan Irving, Jennifer Richardson, Jim West, Olga Vasiljeva, Shouchun Liu, Yuanhui Huang, Linnea Diep, Li Mei, Stephen J. Moore, Michael B. Winter, David Koditek, Wendy Yu, Joel Shen, Veena Vinod, Clayton White, Laurie Wong, Sherry L. LaPorte, Leila M. Boustany
Supplementary Data from A Probody T Cell–Engaging Bispecific Antibody Targeting EGFR and CD3 Inhibits Colon Cancer Growth with Limited Toxicity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3adc29ea72f3527e383a8169626dde60
https://doi.org/10.1158/0008-5472.22432599.v1
https://doi.org/10.1158/0008-5472.22432599.v1
Autor:
W. Michael Kavanaugh, Marcia Belvin, Bryan Irving, Jennifer Richardson, Jim West, Olga Vasiljeva, Shouchun Liu, Yuanhui Huang, Linnea Diep, Li Mei, Stephen J. Moore, Michael B. Winter, David Koditek, Wendy Yu, Joel Shen, Veena Vinod, Clayton White, Laurie Wong, Sherry L. LaPorte, Leila M. Boustany
T cell–engaging bispecific antibodies (TCB) are highly potent therapeutics that can recruit and activate cytotoxic T cells to stimulate an antitumor immune response. However, the development of TCBs against solid tumors has been limited by signific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19dac67976d8b44d65c32bb86621e8ad
https://doi.org/10.1158/0008-5472.c.6514182
https://doi.org/10.1158/0008-5472.c.6514182
Publikováno v:
Blood. 140:8336-8337
Autor:
Lilley Leong, Tony Byun, Benjamin Kim, Ian Huck, Abel Silva, Joanne Chan, Young Cho, John Liu, Christopher J. Horvath, Stephen J. Moore, Sandip Panicker
Publikováno v:
Blood. 140:1666-1667